• Athenahealth (NASDAQ: ATHN) was initiated with a Neutral rating at Goldman Sachs. Jefferies started shares of the stock with a Buy rating and $46 target, as they believe their estimates could prove conservative given potential upside from new and existing physicians adopting athenaClinicals.
• Kaufman Bros initiated Marvell Technology (NASDAQ: MRVL) with a Hold rating and $18 target, as they believe near-term growth prospects remain uncertain and recommends waiting for more favorable entry points.
  
• The firm also initiated Broadcom Corporation (NASDAQ: BRCM) with a Hold rating and $35 target, and believes the company's growth prospects are priced into shares following the recent rally, and started shares of Nvidia Corporation (NASDAQ: NVDA) with a Buy rating and $42 target, as they believe the company's growth opportunity and competitive strength remain intact and would be buyers at current levels.

• Goldman started shares of Sara Lee (NYSE: SLE) with a Neutral rating and $16 target.
  
• UBS initiated US BioEnergy (NASDAQ: USBE) with a Neutral rating.
  
• Bear Stearns inititated CarMax (NYSE: KMX) with an Underperform rating.
  
• Wachovia started Teekay Offshore Partners (NYSE: TOO) and Holly Energy Partners (NYSE: HEP) with Market Perform ratings.

Analyst initiations: ATHN, MRVL, BRCM and NVDA originally appeared on BloggingStocks on Tue, 30 Oct 2007 11:15:00 EST. Please see our terms for use of feeds.